Rousselot teams up with Pharmatech for advanced medicated gummies

Global ingredients business Rousselot has collaborated with Norwegian medical supplies firm Pharmatech to develop what is believed to be the sector’s first range of nutraceutical confectionery gummies.

The two companies’ teams reportedly worked closely from initial stages of product development, throughout all industrial trials to create a specific sugar-free recipe, to optimise the production process and lower the production costs.

As Rousselot explained, the new series is based on its SiMoGel solution launched last year, and enables the production of fortified gummies in a starch free environment, eliminating the risk of cross-contamination associated with the production in starch moulds.

The optimised production process enables to create gummies with unmatched gelatin texture with only a few minutes of drying.

“The partnership between Pharmatech and Rousselot goes back a long way and we were delighted to support them in this pioneering project with SiMoGel, especially since they already had the necessary equipment for moulding the gummies. It was a pleasure to see Pharmatech operators produce high-quality, fortified gummies within a few hours.” explained Jeff Daelman, Product & BD manager Rousselot.

Geir Andreas Lund, business manager at Pharmatech, added: “SiMoGel was proposed to us in early 2018 as we had been looking for a stable gelatin-based formulation, starch free and easy to produce and this sounded perfect for our innovation projects. By using the product we now have the ability to produce more complex formulations with ingredients that are not suitable for standard gelatin qualities.”

“The fact SiMoGel is also available in a bovine version is an added benefit which opens up a larger market”, continues Lund. “Rousselot made the formulation process extremely smooth by providing us with SiMoGel samples and assisting on-site during the trials. Thanks to the combined effort of both our teams and the good technical advice from Rousselot, the end result was very much satisfactory.”

Pharmatech is now able to offer a high-quality solution for all customers looking for premium functional, nutraceutical or medicinal confectionery, produced in a pharmaceutical FDA-approved facility. The flexible nature of the production process allows to scale the batch size to the customer needs, starting from as little as 500 kg, meaning between 75,000 and 250,000 gummies.

Related content

Leave a reply

Do NOT follow this link or you will be banned from the site!